Abstract
Pyroglutamic acidosis (PGA) remains under-recognised among practising clinicians. Predisposing factors are common. We present a recent case of pyroglutamic acidosis and highlight the role of drug-drug/drug-body interactions, as well as the necessity of good communication between clinicians at the bedside, and scientists at the bench.